Article
Inhibitory effects of aviptadil on the SARS-CoV-2 nsp10/ nsp16 protein complex
2021-02-16
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in late 2019, causes COVID-19, a disease that has been spreading rapidly worldwide. In human lung epithelial cells and monocytes, RLF-100 (aviptadil) has been found to inhibit the RNA replication machinery of SARS-CoV-2, which includes several non-structural proteins (nsp) that play essential roles in synthesizing and replicating viral RNA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b121f561-f35f-53b3-ba7f-f152358cdaef
- DOI
- 10.21203/rs.3.rs-191980/v1
